NOT_YET_RECRUITING
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
The purpose of this study is to pilot test and evaluate an existing tailored ALEX Research Portal to navigate Black and Hispanic adult cancer patients and their family members through referral to cancer clinical trials.
Conditions:
🦠 Cancer
πŸ—“οΈ Study Start (Actual) 20 December 2023
πŸ—“οΈ Primary Completion (Estimated) 19 December 2024
βœ… Study Completion (Estimated) 31 August 2027
πŸ‘₯ Enrollment (Estimated) 350
πŸ”¬ Study Type INTERVENTIONAL
πŸ“Š Phase NA
Locations:
πŸ“ Gainesville, Florida, United States
πŸ“ Miami, Florida, United States

πŸ“‹ Eligibility Criteria

Description

    Inclusion Criteria:

    • * An adult 18 to 100 years of age,
    • * Able to read English or Spanish at least an eighth-grade level,
    • * From a racial/ethnic background historically underrepresented in cancer clinical trials (e.g. Blacks or African Americans and/or Hispanics or Latinos),
    • * Have an email account or the ability to receive texts,
    • * Willingness to be re-contacted,
    • * Be a resident of the state of Florida.

    Exclusion Criteria:

    • * Unable to read English or Spanish at least at eighth-grade level
    • * Does not have an email account or the ability to receive texts
    • * Unwilling to be re-contacted
    • * Non resident of the state of Florida.
Ages Eligible for Study: 18 Years to 100 Years (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes

πŸ—“οΈ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 27 October 2022
  • First Submitted that Met QC Criteria 15 December 2022
  • First Posted 19 December 2022

Study Record Updates

  • Last Update Submitted that Met QC Criteria 7 December 2023
  • Last Update Posted 11 December 2023
  • Last Verified December 2023